Posts by: Patricia Inacio, PhD

News

A pilot project in the United Kingdom is testing a wrist device that is worn like a watch, called Personal Kinetigraph (PKG), to help Parkinson’s patients and their specialist healthcare ... Read more

April 17, 2019April 17, 2019

Researchers Receive $1 Million to Identify New Genes Involved in PD

News

A project to identify new genes involved in the development of Parkinson’s disease has received $1 million in funding from the National Science Foundation (NSF). The grant will be shared ... Read more

April 5, 2019April 5, 2019

Phase 1/2 Trial to Test Investigational Therapy RTB101 in Parkinson’s Disease

News

A new Phase 1/2a clinical trial will investigate resTORbio’s therapy candidate RTB101, alone or in combination with sirolimus, as a potential treatment for Parkinson’s disease. Researchers plan to enroll 45 ... Read more

March 21, 2019March 21, 2019

ProMIS to Present Data on Potential of Antibodies to Target Toxic Alpha-Synuclein in Parkinson’s

News

ProMIS Neurosciences will present evidence of the selectivity of several of its antibody candidates to target the toxic forms of alpha-synuclein, a key component of Lewy bodies that underlie the development of Parkinson’s disease. ... Read more

March 13, 2019March 13, 2019

Anavex 2-73 Trial Recruitment Reaches Halfway Mark

News

A Phase 2 trial evaluating the efficacy and safety of investigational Anavex 2-73 as a treatment for Parkinson’s disease dementia has recruited half of its targeted patients, the therapy’s developer, Anavex Life Sciences, has ... Read more

March 6, 2019March 12, 2019

Exercise Improves Cognitive Function in Parkinson’s, Review Finds

News

Exercise has the potential to improve cognitive function in people with Parkinson’s disease, and has positive effects on motor symptoms, according to a recent literature review study. “The potential ... Read more

February 27, 2019March 5, 2019

AbbVie, Voyager Team Up to Develop Antibodies for Parkinson’s, Other Diseases

News

AbbVie and Voyager Therapeutics have extended their collaboration to co-develop and commercialize antibodies that target the toxic forms of alpha-synuclein to treat Parkinson’s disease and other synucleinopathies. The collaboration will combine AbbVie’s expertise in ... Read more

February 15, 2019February 18, 2019

ProMIS Neurosciences Develops Antibodies Targeting Toxic Forms of Alpha-Synuclein

News

ProMIS Neurosciences has identified several antibody candidates that specifically target the toxic forms of alpha-synuclein, a key component of Lewy bodies that underlie the development of Parkinson’s disease. In vitro (in the lab) ... Read more

February 5, 2019February 5, 2019

Gene Therapy Preserves Nerve Fibers in Mouse Model of Severe Neurodegeneration

News

An investigational gene therapy was able to preserve nerve axons — long projections that connect nerve cells and transport information — in a mouse model of severe axonal degeneration. Because axon ... Read more

February 1, 2019February 1, 2019

Deep Brain Stimulation May Increase Dementia Risk in Some Parkinson’s Patients, Study Suggests

News

Parkinson’s disease patients with mild cognitive impairment who undergo deep brain stimulation are at a higher risk of cognitive decline and dementia, a long term “real-life”study suggests. The study, ... Read more

Posts by: Patricia Inacio, PhD

Patricia Inacio, PhD

Pilot Project Tests Wrist Device That Monitors Symptoms at Home

Researchers Receive $1 Million to Identify New Genes Involved in PD

Phase 1/2 Trial to Test Investigational Therapy RTB101 in Parkinson’s Disease

ProMIS to Present Data on Potential of Antibodies to Target Toxic Alpha-Synuclein in Parkinson’s

Anavex 2-73 Trial Recruitment Reaches Halfway Mark

Exercise Improves Cognitive Function in Parkinson’s, Review Finds

AbbVie, Voyager Team Up to Develop Antibodies for Parkinson’s, Other Diseases

ProMIS Neurosciences Develops Antibodies Targeting Toxic Forms of Alpha-Synuclein

Gene Therapy Preserves Nerve Fibers in Mouse Model of Severe Neurodegeneration

Deep Brain Stimulation May Increase Dementia Risk in Some Parkinson’s Patients, Study Suggests

Pin It on Pinterest